Trial watch: DNA-based vaccines for oncological indications

by Stefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene, Lorenzo Galluzzi
Published 2017-12-01

Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target

by Stefano Pierini, Janos L. Tanyi, Fiona Simpkins, Erin George, Mireia Uribe-Herranz, Ronny Drapkin, Robert Burger, Mark A. Morgan, Andrea Facciabene
Published 2020-08-01

Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy

by Andrea Facciabene, Francesco De Sanctis, Stefano Pierini, Edimara S. Reis, Klara Balint, John Facciponte, Jens Rueter, Masahiro Kagabu, Paola Magotti, Evripidis Lanitis, Robert A. DeAngelis, Ronald J. Buckanovich, Wenchao C. Song, John D. Lambris, George Coukos
Published 2017-09-01

Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury

by Jun Lei, Jason M. Rosenzweig, Manoj K. Mishra, Wael Alshehri, Flavia Brancusi, Mike McLane, Ahmad Almalki, Rudhab Bahabry, Hattan Arif, Rayyan Rozzah, Ghada Alyousif, Yahya Shabi, Nader Alhehaily, Wenyu Zhong, Andrea Facciabene, Sujatha Kannan, Rangaramanujam M. Kannan, Irina Burd
Published 2017-07-01